Febrile Ulceronecrotic Mucha-Habermann Disease: Treatment with Infliximab and Intravenous Immunoglobulins and Review of the Literature
Open Access
- 1 January 2012
- journal article
- case report
- Published by S. Karger AG in Dermatology
- Vol. 225 (4) , 344-348
Abstract
Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a rare subtype of pityriasis lichenoides et varioliformis acuta, characterized by an acute onset of ulceronecrotic papules, rapidly coalescing into large ulcers with necrotic crusts, associated with high fever and severe systemic symptoms. We report a case of a 65-year-old woman with a resistant form of FUMHD successfully treated with a tumor necrosis factor-α (TNFα) inhibitor (infliximab). After 1 year of treatment, because of the recurrence of lesions and -occurrence of severe sepsis, we decided to change the therapeutic procedure by introducing intravenous immunoglobulin witch induced a spectacular improvement. Only few cases of FUMHD treated with intravenous immunoglobulin have been reported to date. In our case, we describe the first utilization of TNFα inhibitors in the treatment of FUMHD: TNFα inhibitors may be useful, particularly in resistant cases. Further reports are required to confirm this potential therapeutic option.Keywords
This publication has 38 references indexed in Scilit:
- Febrile ulceronecrotic Mucha–Habermann disease: a rare dermatological emergencyClinical and Experimental Dermatology, 2009
- Self-limited variant of febrile ulceronecrotic Mucha-Habermann disease with polyclonal T-cell receptor rearrangementJournal of the American Academy of Dermatology, 2006
- A Case of Ulceronecrotic Mucha-Habermann Disease with Pulmonary InvolvementDermatology, 2006
- Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with fatal outcomeJournal of the European Academy of Dermatology and Venereology, 2006
- Septic, CD‐30 Positive Febrile Ulceronecrotic Pityriasis Lichenoides et Varioliformis AcutaPediatric Dermatology, 2005
- Febrile ulceronecrotic Mucha-Habermann disease with clonality: A cutaneous T-cell lymphoma entity?Journal of the American Academy of Dermatology, 2004
- Febrile ulceronecrotic Mucha-Habermann's disease managed with methylprednisolone semipulse and subsequent methotrexate therapiesJournal of the American Academy of Dermatology, 2003
- Febrile ulceronecrotic Mucha‐Habermann's disease with fatal outcomeInternational Journal of Dermatology, 1997
- Febrile ulceronecrotic Mucha-Habermann diseaseJournal of the American Academy of Dermatology, 1993
- Febrile Ulceronecrotic Mucha‐Habermann's Disease with Interstitial PneumonitisJournal of Cutaneous Pathology, 1979